SCOLI Genetics

SCOLI Genetics is a genetic test developed in conjunction with EpiDisease, an investee company of ARQUIMEA, which evaluates genetic susceptibility to suffer from Adolescent Idiopathic Scoliosis (AIS).

The AIS is a multifactorial disease in which both the individual’s genetics and the environmental factors contribute to its onset and progression. The test also analyses the susceptibility linked to the progression of the spine curvature, as well as the genetic predisposition to respond successfully to treatment based on the use of a brace.

Through a buccal swab sample, we obtain DNA, and after a sequencing process and a bioinformatics analysis, we evaluate several genetic polymorphisms to provide a calculation of Genetic Risk Scores (GRS) associated with the disease.